SEC 13F Intelligence

Managers / Q1 2020 · view latest →

Birch Grove Capital LP

CIK 0001652355 · 590 MADISON AVENUE, 38TH FLOOR, NEW YORK, NY, 10022 · 212-753-7510

Reported Value
$70M
Q1 2020
Positions
13
Filings on Record
26
2019–present window
Filed
May 15, 2020
original filing

Summary

Birch Grove Capital LP reported $70M in U.S.-listed holdings across 13 positions for Q1 2020.

The portfolio is heavily concentrated: Evolent Health alone accounts for 22.1% of reported value.

Compared with Q4 2019, the fund opened 6 new positions and exited 7.

Portfolio Metrics

Turnover
+18.8%
vs prior filed quarter
Top-10 Concentration
+99.9%
share of reported value
Largest Position
+22.1%
Evolent Health
New / Exited
6 / 7
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $222MQ4 ’18Q1 ’19: $166MQ2 ’19: $131MQ3 ’19: $135MQ3 ’19Q4 ’19: $81MQ1 ’20: $70MQ2 ’20: $121MQ2 ’20Q3 ’20: $185MQ4 ’20: $192MQ1 ’21: $230MQ1 ’21Q2 ’21: $206MQ3 ’21: $212MQ4 ’21: $221MQ4 ’21Q1 ’22: $245MQ2 ’22: $252MQ3 ’22: $256MQ3 ’22Q4 ’22: $202MQ1 ’23: $110MQ2 ’23: $68MQ2 ’23Q3 ’23: $57MQ4 ’23: $23MQ1 ’24: $13MQ1 ’24Q2 ’24: $10MQ3 ’24: $10Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 91.6%Unit: 5.8%Common Stock: 2.3%Closed-End Fund: 0.2%Other: 0.1%
  • US DOMESTIC · 91.6% · $64M
  • Unit · 5.8% · $4M
  • Common Stock · 2.3% · $2M
  • Closed-End Fund · 0.2% · $173,000
  • Other · 0.1% · $44,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
II VI INCNEW+9.00M9.00M+$8M$8M
CHURCHILL CAP CORP IIINEW+300.0K300.0K+$3M$3M
INDEPENDENCE CONTRACT DRILLINGNEW+212.1K212.1K+$297,000$297,000
ECCEAGLE PT CR CO LLCNEW+25.3K25.3K+$173,000$173,000
EAGLE BULK SHIPPING INCNEW+350.0K350.0K+$44,000$44,000
EXMOCEXXON MOBIL CORPNEW+700.0K700.0K+$20,000$20,000
NUANCE COMMUNICATIONS INCSOLD OUT8.23M0$9M$0
INDEPENDENCE CONTRACT DRILLINGSOLD OUT4.25M0$4M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

10 positions
#IssuerClass% PortfolioValueShares
1EVOLENT HEALTH INCNOTE 2.000% 12/022.06%$15M17.23M
2JAZZ INVESTMENTS I LTDNOTE 1.875% 8/118.56%$13M13.40M
3AMAG PHARMACEUTICALS INCNOTE 3.250% 6/018.53%$13M16.50M
4II VI INCNOTE 0.250% 9/011.91%$8M9.00M
5GOLAR LNG LTDNOTE 2.750% 2/110.45%$7M11.24M
6VERINT SYS INCNOTE 1.500% 6/010.14%$7M7.19M
7CHURCHILL CAP CORP IIIUNIT 03/01/20274.29%$3M300.0K
8CHURCHILL CAP CORP IICL A · UNIT 99/99/99993.31%$2M228.2K
9INDEPENDENCE CONTRACT DRILLINGCOM0.42%$297,000212.1K
10ECCEAGLE PT CR CO LLCCOM0.25%$173,00025.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2024$10M3Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$10M4Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$13M6May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$23M9Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$57M12Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$68M13Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023REVEALED$110M20May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$202M33Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$256M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$252M41Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$245M38May 17, 202213F-HRchanges · EDGAR ↗
Q4 2021$221M47Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$212M52Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$206M46Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$230M50May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$192M40Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$185M46Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$121M43Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$70M13May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$81M16Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$135M29Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$131M13Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$166M23May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$222M28Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.